ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xeplion 50 mg, Retardsuspension zur intramuskulären Injektion - Spritze(n)
60466002 PPJanssen-Cilag AG
Xeplion 50 mg, Retardsuspension zur intramuskulären Injektion15.12.2010
  15.12.2010
Paliperidone (N05AX13) 
WHO-DDD14.12.2020
01.05.Spritze(n)
01.05. 
B  
YesNeuroleptikum
IP 
285.97No
    
10 %344.70
  
7680604660027Synthetika
4787770 
Composition
paliperidonum 50 mg ut paliperidoni palmitas, polysorbatum 20, macrogolum 4000, natrii dihydrogenophosphas dihydricus, acidum citricum monohydricum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.
Packungsbestandteile
Retardsuspension zur intramuskulären Injektion
Aqua ad Iniectabilia q.S. ad Suspensionem pro 0.5 Ml
 
Active AgentDose
Paliperidonum50 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Disodium Phosphate 
Macrogol4000
Sodium Dihydrogenophosphate Dihydrate 
Sodium Dihydrogenophosphate Monohydrate 
Polysorbatum 20 
Source
Data was imported : 06.07.2018
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
 
2019 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home